Literature DB >> 24038957

Topology and membrane anchoring of the lysosomal storage disease-related protein CLN5.

Heidi Larkin1, Maria Gil Ribeiro, Christine Lavoie.   

Abstract

One late infantile variant of the neurodegenerative disease neuronal ceroid lipofuscinosis (NCL) is caused by a mutation in the CLN5 gene. CLN5 encodes a lysosomal glycoprotein whose structure and function have not yet been clearly defined. In the present study, we used epitope-tagged CLN5 to determine the topology and solubility of the CLN5 protein. Our results indicated that CLN5 is synthesized as a type II transmembrane (TM) glycoprotein with a cytoplasmic N-terminus, one TM segment, and a large luminal C-terminal domain containing an amphipathic helix (AH). The cytoplasmic and TM domains were rapidly removed following signal-peptide cleavage, and the resulting mature CLN5 was tightly associated with the lumen of the membrane through the AH. CLN5 pathological mutants deprived of AH lose their membrane association, are retained in the endoplasmic reticulum, and are rapidly degraded by the proteasomal machinery. We experimentally define the topology of CLN5 and demonstrate the existence of an AH that anchors the protein to the membrane. Our work sheds light on the basic properties of CLN5 required to better understand its biological functions and involvement in NCL pathogenesis.
© 2013 WILEY PERIODICALS, INC.

Entities:  

Keywords:  CLN5; amphipathic helix; neuronal ceroid lipofuscinoses (NCL); topology; transmembrane domain

Mesh:

Substances:

Year:  2013        PMID: 24038957     DOI: 10.1002/humu.22443

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  7 in total

1.  Proteolytic processing of the neuronal ceroid lipofuscinosis related lysosomal protein CLN5.

Authors:  Bhagya De Silva; Jessie Adams; Stella Y Lee
Journal:  Exp Cell Res       Date:  2015-09-03       Impact factor: 3.905

Review 2.  A lysosomal enigma CLN5 and its significance in understanding neuronal ceroid lipofuscinosis.

Authors:  I Basak; H E Wicky; K O McDonald; J B Xu; J E Palmer; H L Best; S Lefrancois; S Y Lee; L Schoderboeck; S M Hughes
Journal:  Cell Mol Life Sci       Date:  2021-04-01       Impact factor: 9.261

3.  Characterization of neurological disease progression in a canine model of CLN5 neuronal ceroid lipofuscinosis.

Authors:  Elizabeth J Meiman; Grace Robinson Kick; Cheryl A Jensen; Joan R Coates; Martin L Katz
Journal:  Dev Neurobiol       Date:  2022-04-28       Impact factor: 3.102

4.  Loss of CLN7 results in depletion of soluble lysosomal proteins and impaired mTOR reactivation.

Authors:  Tatyana Danyukova; Khandsuren Ariunbat; Melanie Thelen; Nahal Brocke-Ahmadinejad; Sara E Mole; Stephan Storch
Journal:  Hum Mol Genet       Date:  2018-05-15       Impact factor: 6.150

Review 5.  Recent Insights into NCL Protein Function Using the Model Organism Dictyostelium discoideum.

Authors:  Meagan D McLaren; Sabateeshan Mathavarajah; Robert J Huber
Journal:  Cells       Date:  2019-02-02       Impact factor: 7.666

6.  KCTD7 mutations impair the trafficking of lysosomal enzymes through CLN5 accumulation to cause neuronal ceroid lipofuscinoses.

Authors:  Yalan Wang; Xiaotong Cao; Pei Liu; Weijia Zeng; Rui Peng; Qing Shi; Kai Feng; Pingzhao Zhang; Huiru Sun; Chenji Wang; Hongyan Wang
Journal:  Sci Adv       Date:  2022-08-03       Impact factor: 14.957

7.  Visual system pathology in a canine model of CLN5 neuronal ceroid lipofuscinosis.

Authors:  Grace Robinson Kick; Elizabeth J Meiman; Julianna C Sabol; Rebecca E H Whiting; Juri Ota-Kuroki; Leilani J Castaner; Cheryl A Jensen; Martin L Katz
Journal:  Exp Eye Res       Date:  2021-06-30       Impact factor: 3.770

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.